Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLungCancerTeam Member asked a question 💭
Goodyear, AZ
September 26, 2024
 · 
Reactions
A MyLungCancerTeam Member

It depends on the type, stage and whether you had Keytruda with chemotherapy or Keytruda alone. There are a few recent studies on long term benefits, but you have to look for one that fits your situation.
Here is a good article on long term efficacy when taken with chemo as a 1st-line treatment. It is for patients with metastatic NSCLC, comparing PFS and OS between those that had Immuno-chemtherpy and those that had chemo alone.
https://www.merck.com/news/five-year-data-for-m...
Like I said, there are a few recent ones, but you have to search on what you have had done/your situation.
I have Stage 4 Squamous NSCLC. I had 4 cycles of Keytruda with carboplatin and paclitaxel and just finished 2 years (34 infusions) of Keytruda. I'm doing well, though there are suspicious areas on my most recent PET/CT scan. They attribute them to infection, rather than cancer. None are in areas common to squamous cell carcinoma.
Stay positive!
Tony

Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC) - Merck.com
Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC) - Merck.com
September 28, 2024
A MyLungCancerTeam Member

It's starting to work on my lymph nodes. But in general it depends on how your body responds. Took 5 months to see any response in my case.

September 27, 2024
A MyLungCancerTeam Member

Double whammy! My thoughts and prayers are with you.

September 27, 2024
A MyLungCancerTeam Member

What kind of cancer and where you taking any other chemo?

September 27, 2024
MyLungCancerTeam

Keytruda (pembrolizumab) has shown significant success in treating certain types of lung cancer. Here are some key points:

- FDA Approval: Keytruda is approved by the FDA for treating metastatic small cell lung cancer and various non-small cell lung cancers (NSCLC)
- Mechanism: It works by binding to the PD-1 receptor, Show Full Answer

Keytruda (pembrolizumab) has shown significant success in treating certain types of lung cancer. Here are some key points:

- FDA Approval: Keytruda is approved by the FDA for treating metastatic small cell lung cancer and various non-small cell lung cancers (NSCLC).
- Mechanism: It works by binding to the PD-1 receptor, enhancing the body's immune response to destroy cancer cells.
- Clinical Trials: A clinical trial in 2016 demonstrated that Keytruda improved overall survival in people with NSCLC who had the PD-L1 protein on 50% or more of their tumor cells.
- Combination Therapy: It can be used alone or in combination with chemotherapy for advanced-stage lung cancer.

For more detailed information, you can visit the Keytruda page on MyLungCancerTeam: [Keytruda (Pembrolizumab) for Lung Cancer](https://www.mylungcancerteam.com/treatments/key...).

September 26, 2024

Related Questions

View All
A MyLungCancerTeam Member asked a question 💭
Lewisburg, TN

A MyLungCancerTeam Member asked a question 💭
Huntsville, TX